Dokumendiregister | Ravimiamet |
Viit | REP-1/1197-1 |
Registreeritud | 05.03.2025 |
Sünkroonitud | 06.03.2025 |
Liik | Sissetulev kiri |
Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
Toimik | REP-1/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | European Directorate for the Quality of Medicines & HealthCare |
Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
Vastutaja | Signe Leito (RA, Peadirektori asetäitja valdkond, Labor) |
Originaal | Ava uues aknas |
1
Signe Leito
Saatja: [email protected] Saatmisaeg: teisipäev, 4. veebruar 2025 13:13 Adressaat: Signe Leito Teema: Survey: Addition to the WP of Group 17: Sodium Patent Blue and Sodium Patent Blue solution for injection : EDQM-2025-00566-mail
Please make sure to include in any reply our mail reference: EDQM-2025-00566-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed addition of the monographs on Sodium Patent Blue and Sodium Patent Blue solution for injection to the work programme of Group 17.
In order to have access to the survey, please copy and paste this link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=554777&lang=en Deadline for replies: 7 March 2025. Thank you. With kind regards On behalf of Amela Saracevic ___ Villy Nikolova Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
2
https://www.edqm.eu / https://www.edqm.eu/store Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-00566-mail
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Euroopa farmakopöa töökava asjus | 05.03.2025 | 1 | REP-1/1197-2 | Väljaminev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |